NEW ORLEANS – Acuvue Oasys With Transitions Light Intelligent Technology Contact Lenses will be available in the U.S. and Canada April 1 and globally afterwards, a Johnson & Johnson Vision representative told Primary Care Optometry News here at SECO.
As with Transitions spectacle lenses, these Acuvue Oasys contacts darken in response to bright light.
However, developers needed to minimize the cosmetic change with the contacts, Zohra Fadli, J&J director of sphere, light management and lens care platform, told PCON.
“The edge-to-edge photochromic technology, which covers the entire iris, will appear differently on differently colored eyes,” she said. “We came up with the perfect combination to provide patient benefit and minimize the change in appearance on the eye.”
Fadli said the photochromic molecules in these contact lenses are completely different than what is in the Transitions spectacle lenses and are built into the entire lens homogenously.
“The lenses are cured with light, but they also block light, so we had to find a sweet spot to cure the lenses,” Fadli said.
She noted that the Transitions Light Intelligent Technology works in these lenses even when the lenses are clear.
“The photochromic molecules don’t need to be activated,” Fadli said, satisfying an unmet need in patients who complain about bright artificial light.
“It offers visual comfort under artificial lights, even when not dark,” she said.
They filter up to 15% of high-energy visible (HEV)/blue light when not activated. Outdoors, they filter up to 70% HEV, 100% UVB and 99% UVA, she said.
These contacts have compared favorably to regular Acuvue Oasys lenses in a variety of situations, Fadli said, and a study showed that patients’ photostress recovery was improved wearing Acuvue Oasys with Transitions.
She noted that the tint in Transitions spectacle lenses is dependent on temperature, while the contact lenses, constantly bathed in tear film, are at a consistent temperature. The contacts fade back to clear faster than the spectacle lenses, she said.
Doctors will receive demonstration tools to show patients how the 2-week lens works. – by Nancy Hemphill, ELS, FAAO
Disclosure: Fadli is employed by Johnson & Johnson Vision.